Vernon Harvey - Auckland City Hospital

Vernon Harvey

Auckland City Hospital

Auckland, Auckland | New Zealand

Main Specialties: Oncology

Vernon Harvey - Auckland City Hospital

Vernon Harvey

Introduction

Primary Affiliation: Auckland City Hospital - Auckland, Auckland , New Zealand

Specialties:

Publications

32Publications

732Reads

-Profile Views

Bias in survival estimates created by a requirement for consent to enter a clinical breast cancer registry.

Cancer Epidemiol 2019 Feb;58:178-183

Auckland Breast Cancer Register, Greenlane Clinical Centre, Auckland District Health Board, Auckland, New Zealand; Regional Cancer and Blood Centre, Auckland District Health Board, Auckland, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2018.12.005DOI Listing
February 2019
7 Reads
2.558 Impact Factor

Predicting nonadherence to adjuvant endocrine therapy in women with early stage breast cancer.

Psychooncology 2018 09 14;27(9):2096-2103. Epub 2018 Jun 14.

Discipline of Oncology, Oncology, Auckland, New Zealand.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pon.4771
Publisher Site
http://dx.doi.org/10.1002/pon.4771DOI Listing
September 2018
4 Reads
2.443 Impact Factor

The impact of different tumour subtypes on management and survival of New Zealand women with Stage I-III breast cancer.

N Z Med J 2018 05 18;131(1475):51-60. Epub 2018 May 18.

Medical Oncologist, Waikato District Health Board, Hamilton.

View Article

Download full-text PDF

Source
May 2018
17 Reads

The use of trastuzumab in New Zealand women with breast cancer.

Asia Pac J Clin Oncol 2018 Apr 30;14(2):e152-e160. Epub 2017 Aug 30.

University of Waikato, New Zealand.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/ajco.12766
Publisher Site
http://dx.doi.org/10.1111/ajco.12766DOI Listing
April 2018
7 Reads
1.058 Impact Factor

Ethnic disparities in breast cancer survival in New Zealand: which factors contribute?

BMC Cancer 2018 01 8;18(1):58. Epub 2018 Jan 8.

National Institute of Demographic and Economic Analysis, The University of Waikato, Hamilton, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3797-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759270PMC
January 2018
12 Reads
3.362 Impact Factor

Treatment and survival disparities by ethnicity in New Zealand women with stage I-III breast cancer tumour subtypes.

Cancer Causes Control 2017 Dec 13;28(12):1417-1427. Epub 2017 Oct 13.

Waikato District Health Board, Hamilton, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-017-0969-9DOI Listing
December 2017
43 Reads
2.735 Impact Factor

Stage of breast cancer at diagnosis in New Zealand: impacts of socio-demographic factors, breast cancer screening and biology.

BMC Cancer 2016 Feb 19;16:129. Epub 2016 Feb 19.

Waikato Clinical School, University of Auckland, Hamilton, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-016-2177-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761194PMC
February 2016
10 Reads
3.362 Impact Factor

ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.

Breast Cancer Res Treat 2015 Dec 21;154(3):543-55. Epub 2015 Nov 21.

Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-015-3634-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730949PMC
December 2015
44 Reads
3.940 Impact Factor

Reply to: letter to the editor "subcutaneous herceptin therapy".

J Clin Pharmacol 2013 Dec 21;53(12):1343-4. Epub 2013 Sep 21.

Christchurch Clinical Studies, Christchurch, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcph.172DOI Listing
December 2013
3 Reads

Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.

J Natl Cancer Inst 2010 Aug 14;102(16):1253-62. Epub 2010 Jul 14.

Sydney Cancer Centre, Gloucester House 6, Royal Prince Alfred Hospital, Missenden Rd, Camperdown, NSW 2050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djq245DOI Listing
August 2010
23 Reads
12.583 Impact Factor

Phase III trial comparing three doses of docetaxel for second-line treatment of advanced breast cancer.

J Clin Oncol 2006 Nov 10;24(31):4963-70. Epub 2006 Oct 10.

Department of Oncology, Auckland Hospital, Private Bag 92-024, Auckland, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.05.0294DOI Listing
November 2006
7 Reads
18.428 Impact Factor

A durable complete remission between two isolated presentations of metastatic breast cancer, the second with intracardiac disease.

Clin Breast Cancer 2006 Jun;7(2):162-3

Department of Medical Oncology, Regional Cancer and Blood Service, Auckland City Hospitial, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2006.n.027DOI Listing
June 2006
2 Reads
2.107 Impact Factor

Quality-of-life valuations of advanced breast cancer by New Zealand women.

Pharmacoeconomics 2006 ;24(3):281-92

School of Population Health, University of Auckland, Auckland, New ZealandHealth Outcomes Associates Ltd, Auckland, New Zealand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00019053-200624030-00007DOI Listing
May 2006
2 Reads
2.450 Impact Factor

Phase II study of efficacy, safety, and pharmacokinetics of trastuzumab monotherapy administered on a 3-weekly schedule.

J Clin Oncol 2005 Apr;23(10):2162-71

Vall d'Hebron, University Hospital, Department of Medical Oncology, Pg Vall d'Hebron, 119-129, E-08035 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/23/10/2162.full.pdf
Web Search
http://www.jco.org/cgi/doi/10.1200/JCO.2005.01.014
Publisher Site
http://dx.doi.org/10.1200/JCO.2005.01.014DOI Listing
April 2005
15 Reads
18.428 Impact Factor

Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 following chemotherapy for advanced breast cancer.

ANZ J Surg 2003 Nov;73(11):905-8

Departments of Endocrinology and Oncology, Auckland Hospital, Auckland, New Zealand.

View Article

Download full-text PDF

Source
November 2003
14 Reads
1.118 Impact Factor

The Auckland Breast Cancer Register: a special project of the Auckland Breast Cancer Study Group.

N Z Med J 2003 Oct 24;116(1184):U648. Epub 2003 Oct 24.

North Shore Hospital, Auckland, New Zealand.

View Article

Download full-text PDF

Source
October 2003
2 Reads

Top co-authors

Alan S Coates
Alan S Coates

European Institute of Oncology

7
Ross Lawrenson
Ross Lawrenson

Waikato Clinical School

7
Ian Campbell
Ian Campbell

Cancer Genetics Laboratory

7
Sanjeewa Seneviratne
Sanjeewa Seneviratne

Waikato Clinical School

6
Patrick Neven
Patrick Neven

Multidisciplinary Breast Center

5
Aron Goldhirsch
Aron Goldhirsch

European Institute of Oncology

5
Diana Sarfati
Diana Sarfati

University of Otago

4
Olivia Pagani
Olivia Pagani

Institute of Oncology of Southern Switzerland

4
Mark Elwood
Mark Elwood

Harvard School of Public Health

4